Constructing Portfolios That Differ From the Index
May 31, 2019
DeGulis, John P.
The First Half of 2019 Expected to Be Rough for the Biotech Sector
March 15, 2019
Singh, Hartaj
Good Management Teams and Good Science are Creating Opportunities in Biotech
March 08, 2018
Singh, Hartaj
Biotech Space Lining Up for New Product Cycle
April 21, 2017
Singh, Hartaj
Opportunities in Regenerative Medicine, Cancer Immunotherapy Markets for Value Investors
July 06, 2015
Handpicked Stocks in Emerging Pharmaceuticals
November 24, 2014
Managing a Growth Portfolio with a Focus on Company-Specific Metrics
September 08, 2014
Seeking Growth at a Reasonable Price While Considering Secular Themes
May 02, 2014
Biotechnology Capital Inflows Reach Historic Highs
April 07, 2014
Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs
August 23, 2013
Opportunities in Hepatitis C and Genomic Technologies
April 08, 2013
FDA Approvals Accelerate and Opportunities Arise in Hepatitis C Market
April 08, 2013
Hepatitis C Therapies Propel Growth in Biotech
August 30, 2012
"common Sense" Investment Management - Kendall J. Anderson - Anderson Griggs Portfolio Management
November 14, 2011
Defensive Plays In The Defense Space - Michael F. Ciarmoli - Keybanc Capital Markets Inc.
November 14, 2011
Investing In Small- & Midcap Biotech Companies - Dr. Jason Kantor - Rbc Capital Markets
April 04, 2011
Health Care Services & Tech Outlook - Ross Muken - Deutsche Bank Securities, Inc.
November 15, 2010
Overview Of Midwestern Regional Bank Metrics - Craig Siegenthaler - Credit Suisse
April 05, 2010
Update On Science Tools & Diagnostics - Isaac Ro - Leerink Swann & Company
January 25, 2010
Investing In Regulated Electric Utilities - Marc De Croisset - Macquarie Capital (usa) Inc.
May 18, 2009
Sector-focused Growth Management - Frank Mastrapasqua & Mauro M. Mastrapasqua - Mastrapasqua Asset Management
June 09, 2008
K.CRONK / T.LAPOINTE - COLUMBIA MANAGEMENT GROUP
June 27, 2005
KEVIN CAREY - 1ST SOURCE CORPORATION INVESTMENT ADVISORS INC
July 19, 2004
JONATHAN ROTHBERG - CURAGEN CORPORATION (CRGN)
March 08, 2004
L.holtz / Y.lipsker - Roger Engemann & Associates
July 28, 2003
Wayne Yetter - Synavant Inc (snvt)
September 13, 2002
Large Cap Biotechnology & Life Sciences: Ronald Renaud - Bear, Stearns & Co
September 13, 2002
Ian Smith - Vertex Pharmaceuticals Inc (vrtx)
June 02, 2002
R.schwarzkopf / S.gleason - Kayne Anderson Rudnick Investment Mgmt Llc
February 25, 2002
George Robson - Dendrite International (drte)
September 14, 2001
Japanese Semiconductor Companies & Electronics: Scott Foster - Lehman Brothers
September 12, 2001
Mary Ann Gray - Federated Kaufmann Fund
June 07, 2001
Mark Frevert - Enron Wholesale Services (ene)
May 31, 2001
Outlook For Biotechnology Stocks: William Slattery - Deerfield Management
December 18, 2000
D.altabef / D.katz - Matrix Asset Advisors
December 18, 2000
George Kellner - Kellner, Dileo & Co
November 20, 2000
Emerging Pharamaceutical Companies : Corey Davis - Chase H&q
January 13, 2000
Joe C. Cook Jr. - Amylin Pharmaceuticals (amln)
January 13, 2000
Ian Prosser - Bass Plc (bass.l)
January 03, 2000
Roundtable Forum: Major Chemicals
December 20, 1999
Biotherapeutics Stocks : Michael G. King Jr. - Robertson Stephens
December 06, 1999
